Research Article
Immunologic Response of HIV-Infected Children to Different Regimens of Antiretroviral Therapy: A Retrospective Observational Study
Table 3
Random-effect linear regression analysis of trend of CD4+ count (slope, cells/mm3/6 month) at JMC, from April 10 to May 10, 2017.
| Variables | n (%) | Unadjusted %β [95%CI] | value | Adjusted %β [95%CI] | value |
| Sex | Male | 98 (54.75) | 0 | | | | Female | 81 (45.25) | 7.46[−13.61−28.53] | 0.488 | | |
| Age: median (IQR) | 7 (4–9) | 179 (100) | −0.56[−4.24−3.12] | 0.765 | | |
| BMI | Below 5th centile | 140 (78.21) | −19.45[−44.56−5.70] | 0.130 | −5.18[−22.99−12.63] | 0.569 | Above 5th centile | 39 (21.79) | 0 | | 0 | |
| Weight for height | ≤70% | 36 (20.11) | −31.84[−57.96− (−5.72)] | 0.017 | 2.31[−18.10−22.72] | 0.825 | 70–85% | 14 (7.82) | −9.84[−48.62−28.94] | 0.619 | 5.91[−21.17−32.99] | 0.669 | ≥85% | 129 (72.07) | 0 | | 0 | |
| In care of the child | Mother | 24 (13.41) | 16.91[−13.74−47.57] | 0.280 | | | Others | 155 (86.59) | 0 | | | |
| Maternal status | Dead | 33 (18.44) | −3.244[−30.53−24.06] | 0.816 | | | Live | 146 (8156) | 0 | | | |
| Maternal serostatus | Unknown | 18 (10.06) | −5.01[−40.54−30.53] | 0.782 | | | Negative | 161 (89.94) | 0 | | | |
| Paternal status | Dead | 47 (26.26) | 0.32[−23.39−24.03] | 0.979 | | | Live | 132 (73.74) | 0 | | | |
| Residence | Urban | 134 (78.86) | 0 | | | | Rural | 45 (25.14) | −6.59[−31.04−17.87] | 0.598 | | |
| ART group | ABC | 87 (48.60) | 0 | | 0 | | AZT | 92 (51.40) | 30.42[9.89–50.94] | 0.004 | 20.51[6.37−34.65] | 0.004 |
| CD4 count | 162 (117–221) | 179 (100) | 0.72[0.62–0.82] | ≤0.001 | 0.55[0.49−0.69] | ≤0.001 | OI occurred | No | 121 | 0 | | 0 | | Yes | 58 | −49.12[−70.49− (−27.74)] | ≤0.001 | −18.65[−5.49−42.78] | 0.130 |
| Viral load | ≤1000 copies/ml | 146 (83.43) | 0 | | | | >1000 copies/ml | 29 (16.57) | −50.21[−77.71− (−22.71)] | ≤0.001 | −27.68[−47.75− (−7.61)] | 0.007 |
| WHO stage | Stage I | 11 (6.15) | 0 | | 0 | | Stage II | 64 (35.75) | −31.43[−73.23−10.37] | 0.141 | −28.63[−64.05−6.71] | 0.112 | Stage III | 87 (48.60) | −94.64[−136.08− (−53.19)] | ≤0.001 | −47.61[−84.27− (−10.96)] | 0.011 | Stage IV | 17 (9.50) | −151.41[−199.26− (−103.56)] | ≤0.001 | −73.54[−118.27− (−28.81)] | 0.001 |
| Nutritional status | Normal | 102 (57.00) | 0 | | 0 | | SAM | 77 (43.00) | −38.79[−59.28− (−18.30)] | ≤0.001 | −13.42[−35.34−8.50] | 0.230 |
| TB treatment | No | 166 (92.74) | 0 | | 0 | | Yes | 13 (7.26) | −61.14[−103.84− (−18.43)] | 0.005 | −32.58[−65.18−0.21] | 0.050 |
|
|